BIOT
•
Equity
L&G PHARMA BREAKTHROUGH UCITS ETF
TER (bps):
49
AUM (USD m):
18
ISIN:
IE00BF0H7608
Domicile:
Ireland
Share Class Currency:
USD
ESG:
No
Geographical Focus:
Global
As of:
18 Apr 2024
Climate Fund:
No
Benchmark
The Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. it uses a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts. The Index selects stocks that meet certain size and liquidity requirements.
RELATED ARTICLES
MOST READ
1
New Listing
BlackRock expands fixed-maturity range with US Treasury and Italian BTP ETFs
2
Interview
ARK Invest Europe: ‘10 ETFs is plenty’
3
Industry Updates
BlackRock world ETF flash crashes on Deutsche Boerse as liquidity vanishes
4
New Listing
ARK Invest Europe launches innovation, genomics and AI ETFs
5
Industry Updates